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Background: Occupational and environmental exposure to inorganic arsenic leads to development of cancer and
represents a significant health hazard in more than 70 countries. The underlying mechanism for arsenic-induced
carcinogenesis remains unclear. Laboratory studies suggest that arsenic is a poor mutagen but may cause epigenetic
silencing of key tumor suppressor genes such as p16 through DNA hypermethylation. However, the evidence for an
association between human arsenic exposure and abnormal DNA methylation of tumor suppressor genes is lacking.
Findings: Paired case–control studies were conducted involving 40 individuals with high arsenic exposure and
arsenicosis, 40 individuals with similarly high exposure to arsenic but without arsenicosis, and 40 individuals with
normal exposure to arsenic. DNA methylation status of p16 was determined using methylation-specific PCR. Conditional
logistic regression analysis showed that DNA hypermethylation of p16 gene was significantly associated with high
arsenic exposure (Odds Ratio = 10.0, P = 0.0019) independently of the development of arsenicosis (Odds Ratio = 2.0,
P = 0.1343).
Conclusions: High exposure of arsenic in human is positively linked to DNA hypermethylation of p16 gene,
suggesting that epigenetic silencing of key tumor suppressor may be an important mechanism by which arsenic
promotes cancer initiation.
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Introduction
Inorganic arsenic is a widespread pollutant. Human ex-
posure to arsenic can occur occupationally and environ-
mentally. In many Asian developing countries, synthetic
arsenates are commonly used as agricultural insecticides
and poisons. In addition, contamination of arsenic in
drinking water and through improper coal burning and
disposal represents a major health concern, affecting
over 137 million people in more than 70 countries [1].
Chronic arsenic exposure is associated with a range of
adverse health outcomes, including skin lesions (hyper-
pigmentation, keratosis), neuropathy and cardiovascular* Correspondence: gmlu301@sohu.com
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ure are associated with increased risks of cancers in
skin, liver, kidney and bladder [4,5]. However, the mech-
anism(s) underlying arsenic’s carcinogenic potential re-
main elusive.
Laboratory investigations using cell culture and animal
models indicate that arsenic is a poor mutagen [6,7],
suggesting that genetic mutation may not be critically
involved in arsenic-induced tumor development. In con-
trast, it is well-documented that after entering human
body, arsenic is metabolized to monomethylarsonic acid
and dimethylarsenic acid and such reactions rely on
S-adenosylmethionine (SAM) as methyl donor [8]. SAM
is an essential co-factor for cellular methyltransferases in-
cluding DNA methyltransferases (DNMTs), which are
responsible for the generation of 5-methylcytosine in
DNA. It was hypothesized that by interfering with SAMis an Open Access article distributed under the terms of the Creative
commons.org/licenses/by/4.0), which permits unrestricted use, distribution,
he original work is properly credited. The Creative Commons Public Domain
rg/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Descriptive characteristics of study subjects
Parameters Individuals with High arsenic
exposure and arsenicosis
Individuals with High arsenic
exposure and without arsenicosis
Individuals with
low arsenic exposure
Total Subjects 40 40 40
Sex (Male/Female) 27/13 27/13 27/13
Age (mean ± SD years) 44.125 ± 12.015 44.250 ± 11.931 43.650 ± 12.223
Ethnicity (% of Han) 97.5 100 100
Occupation (% of farmers) 92.5 97.5 90








26 (65%) 14 40
High arsenic exposure
and without arsenicosis
19 (47.5%) 21 40
Low arsenic exposure 8 (20%)** 32 40
**P < 0.01.
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mal DNA methylation. Indeed, treating cells with arsenic
altered the global and local DNA methylation patterns
[9-11]. Since DNA methylation at gene promoters is
tightly linked to the regulation of gene expression [12],
arsenic may facilitate tumor initiation and develop-
ment through epigenetic modulation of key oncogenes
and/or tumor suppressors.
p16 (also known as CDKN2A) is a well-established
tumor suppressor. p16 serves as an important regulator
of cell cycle during G1/S phase progression and repre-
sents a critical barriers for cellular transformation [13].
p16 is implicated in a variety of human cancers including
dermatological malignancies [14]. Importantly, in addition
to genetic deletion and mutation, p16 is frequently silenced
in human tumors through DNA hypermethylation [15]. As
an attempt to understand the mechanistic link between ar-
senic exposure and increased cancer risk, we determined
whether high exposure to arsenic in human is associated
with altered DNA methylation of p16 gene.
Results
We conducted a paired case–control study approved by
the Chinese PLA General Hospital review board. 40 case
subjects were recruited from villages in Bameng, Inner
Mongola of China where the drinking water is contami-
nated with high levels of arsenic (>0.05 mg/L, average =
0.6 mg/L). The selection criteria include a clear drinking
history and a positive diagnosis of arsenic poisoning
(arsenicosis). Two cohorts of control subjects, matched
with respect to age, sex, ethnicity and socioeconomical
status, were recruited including: 1) individuals from the
same villages with high arsenic exposure but showed no
clinical signs of arsenicosis; and 2) individuals from the
neighboring villages where the drinking water is not con-
taminated with arsenic (<0.05 mg/L, average = 0.02 mg/L).
Table 1 summarizes the descriptive characteristics of the
study participants. None of the parameters is statistically
significantly different between case and control groups.
Interviews were conducted between trained practi-
tioners and study subjects with a structured epidemio-
logical questionnaire including details about individual’s
demographic factors, drinking water history and condi-
tion, smoking index, alcohol consumption, past medicalhistory and current illness. 3 ml of vein blood were drawn
from study subjects. Whole blood leukocytes were isolated
through centrifugation and stored at −20°C. DNA was ex-
tracted for methylation-specific (MS) PCR reactions to
determine the DNA methylation levels of p16 gene as
described previously [16]. In brief, each sample was
treated with bisulphite to convert unmethylated but
not methylated cytosine to uracil. The samples were
then amplified with two sets of primers targeting p16
promoter regions, one for unmethylated DNA (Forward
5′-TTATTAGAGGGTGGGGTGGATTGT-3′; Reverse
5′-CAACCCCAAACCACAACCATAA-3′) and one for
methylated DNA (Forward 5′- TTATTAGAGGGTG
GGGCGGATCGC-3′; Reverse 5′- GACCCCGAACC
GCGACCGTAA-3′). The PCR products were analyzed
by polyacrylamide gel electrophoresis and ethidium brom-
ide staining. The appearance of a band of ~150 bp indi-
cates the presence of p16 methylation in the blood. A
representative result of the MS-PCR assay with posi-
tive and negative controls is shown in Additional file 1:
Figure S1.
As shown in Table 2, 26 of 40 (65%) subjects in high
arsenic exposure with arsenicosis group had p16 hyper-
methylation, while 19 of 40 (47.5%) subjects in high
arsenic exposure without arsenicosis group were p16
methylation positive. In sharp contrast, only 9 of 40
(20%) subjects in low arsenic exposure group were
p16 methylation positive (P < 0.01, Fisher’s Exact test).
These results suggest that there is a significant correlation
between p16 hypermethylation and arsenic exposure inde-
pendent of the development of arsenicosis.
To extend our analysis, variables collected through inter-
views and MS-PCR results were assigned with quantified
Table 3 Logistic regression analysis results comparing cases to controls with low exposure to arsenic
Variables Regression coefficient Standard error χ2 P-value Odds ratio
Education 0.000000 0.57735 0.00000 1.0000 1.000
Years of drinking water 1.302854 0.76139 2.92805 0.0871 3.680
Smoking Index 0.017927 0.02852 0.39504 0.5297 1.018
Alcohol Consumption 0.677061 0.48951 1.91309 0.1666 1.968
p16 methylation 2.302585 0.74162 9.63981 0.0019 10.000**
**P < 0.01.
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ratios (OR) and estimates of relative risk were calculated
by univariate analysis. To identify variables that were inde-
pendently associated with arsenic exposure, multivariate
analyses were performed using conditional logistic regres-
sion methods. All P-values resulted from two-sided statis-
tical tests. The FREQ and PHREG procedures in Statistical
Package SAS 6.12 were employed.
We first compared case subjects (high exposure to ar-
senic with arsenicosis) to control subjects with minimal
exposure to arsenic. 12 variables were included in the
univariate logistic regression analysis and Table 3 sum-
marizes the results of five of them. DNA hypermethyla-
tion of p16 showed a highly significant association with
case subjects (OR = 10.0,P = 0.0019), while none of the
other variables reached statistical significance.
We next compared case subjects to control subjects
who are exposed to high arsenic levels without arsenico-
sis. 13 variables were included in the univariate logistic
regression analysis and Table 4 summarizes the results
of six of them. The only variables displaying significant
association with case subjects were years of drinking
contaminated water (OR = 1.192, P = 0.0154) and arsenic
concentration in drinking water (OR = 4.2,P = 0.0039).
None of the other variables, including p16 DNA methy-
lation (OR = 2, P > 0.05), reached statistical significance.
Collectively our analysis results suggest that p16 DNA
hypermethylation is significantly associated with high ar-
senic exposure and such association is independent of
whether the subjects develop arsenicosis. On the other
hand, the water drinking history as well as the amountTable 4 Logistic regression analysis results comparing cases t
arsenicosis
Variables Regression coefficient S
Education 0.470004 0
Years of drinking water 0.175220 0
Smoking Index 0.031609 0
Alcohol Consumption −1.323988 0
Arsenic Concentration in water 1.435085 0
p16 methylation 0.693147 0
*P < 0.05; **P < 0.01.of arsenic in the drinking water represent critical risk
factors for arsenic poisoning.
Discussion
Despite significant efforts to eliminate arsenic from in-
dustrial processing and agricultural use, occupational
and environmental exposures to toxic levels of arsenic
are still common in developing countries. Therefore un-
derstanding the link between arsenic intake and adverse
health effects such as cancer will exert significant public
health benefit. The carcinogenic mechanism(s) of arsenic
have been extensively studied in laboratories using ani-
mal and cell culture models. Intriguingly, in contrast to
most chemical carcinogens, arsenic only weakly induces
genetic mutation [7]. On the other hand, multiple groups
have reported that arsenic can induce significant changes
in DNA cytosine methylation. For example, Zhao et al. re-
ported that chronic arsenic treatment in rat liver epithelial
cells induced malignant transformation which was accom-
panied by global DNA hypomethylation [10]. Mass and
Wang showed that exposing human lung A549 cells to so-
dium arsenite produced significant dose-responsive hyper-
methylation at the promoter of p53 tumor suppressor
gene [9]. Furthermore, recently Cui et al. demonstrated
that giving mice arsenic in the drinking water induced for-
mation of lung adenocarcinoma with DNA hypermethyla-
tion of p16 [11]. In the current study, we present data that
human exposed to high levels of arsenic are significantly
more likely to have p16 DNA hypermethylation. Our find-
ings as well as others’ support the hypothesis that arsenic
may act as a potent “epi-mutagen” to epigeneticallyo controls with high exposure to arsenic without
tandard error χ2 P-value Odds ratio
.57009 0.67970 0.4097 1.600
.07234 5.86663 0.0154 1.192*
.02639 1.43463 0.2310 1.032
.68202 3.76851 0.0522 0.266
.49761 8.31708 0.0039 4.200**
.46291 2.24211 0.1343 2.000
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tion at promoters can silence gene expression in a her-
itable manner, this could be a critical mechanism by
which cells exposed to arsenic overcome barriers to
malignant transformation.
Previously Chanda et al. examined human subjects ex-
posed to arsenic-contaminated drinking water in West
Bengal in India and found that DNA hypermethylation
of p53 and p16 positively correlated with arsenic levels
in drinking water [17]. Studies of individuals using arsenic-
rich coal with indoor unventilated stoves in Guangzhou,
China also found trends of increased p16 methylation and
reduced protein expression [18]. Our results are consistent
with these findings. In addition, we for the first time
showed that p16 DNA methylation levels are not signifi-
cantly different between subjects with high exposure to ar-
senic and arsenicosis and subjects with similar arsenic
exposure without arsenicosis. This result excludes the pos-
sibility that p16 DNA hypermethylation is a secondary
pathological consequence of arsenic poisoning. Further-
more, the result suggests that p16 hypermethylation pre-
cedes the development of clinical symptoms and may be an
important risk factor for arsenic-related diseases such as
cancer. This is consistent with clinical observations that
loss of p16 through genetic or epigenetic inactivation is an
early event in tumor progression [19]. A weakness of our
study was the use of whole blood leukocytes for p16methy-
lation analysis. Although this approach has been successful
to study disease-related epigenetic changes [20], samples
from more relevant tissue types such as skin would poten-
tially provide more information.
There are several limitations of current study. First, al-
though the high sensitivity of MS-PCR assay allows us
to measure p16 methylation with a limited amount of
human blood sample, this assay is qualitative rather than
quantitative. Future study with bisulfite sequencing will
be required to validate our findings and to provide a
quantitative assessment of the correlation between ar-
senic exposure and p16 methylation. Second, because
our sampling sites are located in remote areas with no
laboratory access which makes the preservation of RNA
from blood very challenging, our study did not provide a
measurement of p16 RNA and protein expression. Al-
though the association between p16 promoter methyla-
tion and gene repression has been firmly established
[21,22], it would be important in the future to demon-
strate that the epigenetic silencing of p16 affects its ex-
pression. In conclusion, our study demonstrates that
arsenic exposure is associated with p16 DNA hyperme-
thylation in human, which may be an important risk fac-
tor for arsenic-induced tumor development [23,24].
Further investigations are needed to reveal how arsenic
metabolism specifically alters cellular epigenetic state.
As clinically approved drugs targeting DNMTs areavailable, our results suggest that pharmacological re-
versal of DNA hypermethylation at tumor suppressor
genes may offer therapeutic benefits to arsenic exposed
individuals.
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